Deric Park to Chordoma
This is a "connection" page, showing publications Deric Park has written about Chordoma.
Connection Strength
2.270
-
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma. Neuro Oncol. 2018 05 18; 20(6):799-809.
Score: 0.649
-
Diagnosis and treatment of chordoma. J Natl Compr Canc Netw. 2013 Jun 01; 11(6):726-31.
Score: 0.460
-
Chordoma model. J Neurosurg. 2012 Apr; 116(4):799-800; discussion 800.
Score: 0.419
-
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma. Oncologist. 2021 05; 26(5):e847-e858.
Score: 0.197
-
Combination of PARP inhibitor and temozolomide to suppress chordoma progression. J Mol Med (Berl). 2019 08; 97(8):1183-1193.
Score: 0.175
-
Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma. PLoS One. 2015; 10(8):e0134426.
Score: 0.134
-
MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. PLoS One. 2014; 9(3):e91546.
Score: 0.121
-
Identification of repurposed small molecule drugs for chordoma therapy. Cancer Biol Ther. 2013 Jul; 14(7):638-47.
Score: 0.115